FindTrial
Sign In

Role of ultrasound derived kidney index and urine and serum biomarkers in determining the type of kidney injury in patients with liver disease

Role of Renal Resistive Index and Biomarkers (Urine NGAL, Serum IL6) in determining the type of Acute Kidney Injury in patients of Cirrhosis

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2020/09/027816
Enrollment
70
Registered
2020-09-15
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: N179- Acute kidney failure, unspecified Health Condition 2: K746- Other and unspecified cirrhosis ofliver

Interventions

Intervention1: NIL: NIL Control Intervention1: NIL: NIL

Sponsors

Dr Ajay Kumar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Diagnosed cases of cirrhosis with AKI (>= Stage IB, Serum creatinine >= 1.5mg/dL)

Exclusion criteria

Exclusion criteria: Hypertension Diabetes Mellitus Renovascular disease CKD Prior Kidney or Liver Tramsplant Acute or Chronic Renal Replacement Therapy at the time of enrolment Other causes of renal insufficiency like intrinsic causes of AKI other than ATN (like glomerulonephritis) or urinary Obstruction Confirmed pregnancy UTI

Design outcomes

Primary

MeasureTime frame
Differentiating between ATN(Acute Tubular Necrosis) and Non-ATN AKI(Acute Kidney Injury)Timepoint: 3 Days—

Secondary

MeasureTime frame
Differentiating between Pre-renal AKI, HRS(Hepatorenal Syndrome)-AKI, ATN-AKITimepoint: 3 Days—

Countries

India

Contacts

Public ContactDr Roshan George

GIPMER

ajaykumar.aiims@gmail.com9718599226

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026